{"id":1568,"date":"2017-11-07T15:40:38","date_gmt":"2017-11-07T14:40:38","guid":{"rendered":"http:\/\/cilcare.linov.fr\/?p=1568"},"modified":"2023-11-15T09:28:39","modified_gmt":"2023-11-15T08:28:39","slug":"world-pharma-today","status":"publish","type":"post","link":"https:\/\/www.cilcare.com\/jp\/2017\/11\/07\/world-pharma-today\/","title":{"rendered":"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance"},"content":{"rendered":"

Will the promising market for ear disorder treatments follow ophthalmology\u2019s dramatic growth curve?<\/h1>\n

Discover the article by Marie-Pierre Pasdelou, founder & CDO, CILcare, and Michael Naimark, Director of Business Development, CBSET, Inc., published on November 1st, 2017<\/a>.<\/p>\n

Auditory Therapy, Ototoxicity and GLP Compliance: WPT Mag CBSET article<\/a><\/strong><\/p>\n

\"\"<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Will the promising market for ear disorder treatments follow ophthalmology\u2019s dramatic growth curve? Discover the article by Marie-Pierre Pasdelou, founder & CDO, CILcare, and Michael Naimark, Director of Business Development, CBSET, Inc., published on November 1st, 2017. Auditory Therapy, Ototoxicity and GLP Compliance: WPT Mag CBSET article<\/p>","protected":false},"author":3,"featured_media":2353,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-1568","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","entry","has-media"],"yoast_head":"\nWorld Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/2017\/11\/07\/world-pharma-today\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance\" \/>\n<meta property=\"og:description\" content=\"Will the promising market for ear disorder treatments follow ophthalmology\u2019s dramatic growth curve? Discover the article by Marie-Pierre Pasdelou, founder & CDO, CILcare, and Michael Naimark, Director of Business Development, CBSET, Inc., published on November 1st, 2017. Auditory Therapy, Ototoxicity and GLP Compliance: WPT Mag CBSET article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/2017\/11\/07\/world-pharma-today\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-07T14:40:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-15T08:28:39+00:00\" \/>\n<meta name=\"author\" content=\"CILcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"CILcare\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/\",\"url\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/\",\"name\":\"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2017\/11\/WPT-Mag-CBSET-article-pdf.jpg\",\"datePublished\":\"2017-11-07T14:40:38+00:00\",\"dateModified\":\"2023-11-15T08:28:39+00:00\",\"author\":{\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2017\/11\/WPT-Mag-CBSET-article-pdf.jpg\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2017\/11\/WPT-Mag-CBSET-article-pdf.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\",\"name\":\"CILcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"caption\":\"CILcare\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/2017\/11\/07\/world-pharma-today\/","og_locale":"ja_JP","og_type":"article","og_title":"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance","og_description":"Will the promising market for ear disorder treatments follow ophthalmology\u2019s dramatic growth curve? Discover the article by Marie-Pierre Pasdelou, founder & CDO, CILcare, and Michael Naimark, Director of Business Development, CBSET, Inc., published on November 1st, 2017. Auditory Therapy, Ototoxicity and GLP Compliance: WPT Mag CBSET article","og_url":"https:\/\/www.cilcare.com\/jp\/2017\/11\/07\/world-pharma-today\/","og_site_name":"Cilcare","article_published_time":"2017-11-07T14:40:38+00:00","article_modified_time":"2023-11-15T08:28:39+00:00","author":"CILcare","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"CILcare"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/","url":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/","name":"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2017\/11\/WPT-Mag-CBSET-article-pdf.jpg","datePublished":"2017-11-07T14:40:38+00:00","dateModified":"2023-11-15T08:28:39+00:00","author":{"@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac"},"breadcrumb":{"@id":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2017\/11\/WPT-Mag-CBSET-article-pdf.jpg","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2017\/11\/WPT-Mag-CBSET-article-pdf.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/2017\/11\/07\/world-pharma-today\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"World Pharma Today: Auditory Therapy, Ototoxicity and GLP Compliance"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac","name":"CILcare","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","caption":"CILcare"}}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/1568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=1568"}],"version-history":[{"count":1,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/1568\/revisions"}],"predecessor-version":[{"id":11051,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/1568\/revisions\/11051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/2353"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=1568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/categories?post=1568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/tags?post=1568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}